Open AccessImportance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy
Author(s) -
Jonathan A C Sterne,
Margaret T May,
Caroline A. Sabin,
Andrew N. Phillips,
Dominique Costagliola,
Geneviève Chêne,
Amy C. Justice,
Frank de Wolf,
Robert S. Hogg,
Manuel Battegay,
Antonella d'Arminio Monforte,
Gerdtkenheuer Fa,
Schlomo Staszewski,
John S. Gill,
Matthias Egger,
Jordi Casabona,
Francxois Dabis,
Mari M. Kitahata,
Catherine Leport,
Jens D Lundgren,
Peter Reiss,
Michael S. Saag,
Ian V. D. Weller,
Brenda Beckthold,
Benita Yip,
Brenda Dauer,
Jenifer Fusco,
Emilie Lanoy,
Martin Rickenbach,
Valérie Lavignolle,
Ard van Sighem,
Edwige Pereira,
Patrizio Pezzotti,
N. Schmeisser,
Eric Billaud,
François Boué,
Dominique Costagliola,
Xavier Duval,
Claudine Duvivier,
Patricia Enel,
Sandra Fournier,
Jacques Gasnault,
C. Gaud,
Jacques Gilquin,
Sophie Grabar,
M. Khuong,
J. Lang,
Murielle Mary-Krause,
Sophie Matheron,
Marie-Caroline Meyohas,
Gilles Pialoux,
Isabelle Poizot-Martin,
Christian Pradier,
Elisabeth Rouveix,
Dominique Salmon,
Sobel A,
Pierre Tattevin,
Hervé Tissot-Dupont,
Y. Yasdanpanah,
Eleonora Aronica,
V. Tirard-Fleury,
I. Tortay,
Sophie Abgrall,
Marguerite Guiguet,
Emilie Lanoy,
H. Leneman,
Laurence Lievre,
Valérie Potard,
Samir Saidi,
Jean-Louis Vildé,
Catherine Leport,
Patrick Yeni,
Elisabeth Bouvet,
C. Gaudebout,
Béatrice Crickx,
Catherine Picard-Dahan,
Laurence Weiss,
D. Tisne-Dessus,
D. Sicard,
Dominique Salmon,
I. Auperin,
Jean-Paul Viard,
L. Roudière,
R. Fior,
Jean-François Delfraissy,
Cécile Goujard,
Lesprit P,
C. A. Jung,
Jean-Luc Meynard,
O. Picard,
Desplanque N,
Jacques Cadranel,
Charles Mayaud,
Willy Rozenbaum,
François Bricaire,
Christine Katlama,
Serge Herson,
Andre R. Simon,
J. M. Decazes,
J. Molina
Publication year - 2007
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0b013e31815b7dba
Subject(s) - hazard ratio , medicine , confidence interval , cohort , proportional hazards model , viral load , cohort study , antiretroviral therapy , mortality rate , human immunodeficiency virus (hiv) , immunology
The extent to which the prognosis for AIDS and death of patients initiating highly active antiretroviral therapy (HAART) continues to be affected by their characteristics at the time of initiation (baseline) is unclear.